Cow’s Milk Alternative for Infants: Nūmi Raises €3M to Develop Cell-Cultivated Breast Milk
French startup Nūmi (previously MUMilk), a biotech pioneering the production of cell-cultured breast milk, announces it has raised €3 million in pre-seed funding from a group of investors including Heartcore Capital, HCVC, Financière Saint-James, Kima Ventures, and Kost Capital. The new capital will support the expansion of the company’s scientific teams, facilitate its next phase of R&D, and progress toward marketing the company and its products. Nūmi, setting out to revolutionize the infant nutrition industry, states that this achievement represents a significant milestone in furthering its mission to redefine infant health by providing an alternative to cow’s milk for women unable or unwilling to breastfeed. “I am extremely proud to conclude this first round of financing, which marks a crucial stage in our development for …